Close

CorMedix (CRMD) Receives Second CRL from FDA for DefenCath

Go back to CorMedix (CRMD) Receives Second CRL from FDA for DefenCath
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 5.29 -0.13 (2.4%)
Previous Close $5.42    52 Week High $4.54 
Open $5.50    52 Week Low $1.15 
Day High $6.22    P/E N/A 
Day Low $5.13    EPS $-0.55 
Volume 1,777,843